Journal of Society of Preventive Korean Medicine (대한예방한의학회지)

Society of Preventive Korean Medicine (대한예방한의학회)
권호 표지

The Toxicokinetic Characteristics of Korean Traditional Medicines

한약의 독물동태학적 특성

  • Park, Yeong-Chul (GLP Center, Catholic University of Daegu) ;
  • Shin, Heon-Tae (Dept. of Preventive Medicine, Dongshin University, College of Oriental Medicine) ;
  • Lee, Sun-Dong (Dept. of Preventive medicine, School of Oriental Medicine, Sangji University)
  • 박영철 (대구가톨릭대학교 GLP 센터) ;
  • 신헌태 (동신대학교 한의과대학 예방의학교실) ;
  • 이선동 (상지대학교 한의과대학 예방의학교실)
  • Received : 2011.07.26
  • Accepted : 2011.08.16
  • Published : 2011.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Toxicokinetics of Korean Traditional Medicines(TKM) is the description of what rate TKM will enter the body and what happens to it once it is in the body in terms of toxicology. However, it is not easy to understand TKM toxicokinetics because of various factors such as a mixture of 2-30 kinds of herbal materials containing thousands of chemicals, and complex chemical properties. For these reasons, little is known about toxicokinetics of TKM. This study was aimed to characterize and review the absorption, distribution and metabolism of korean traditional medicines in a view of toxicokinetics. For this aim, some of korean traditional medicines were reviewed on a basis of drug-drug interaction, biotransformation and intestinal metabolisms by bacteria. As the factors affecting mainly on toxicokinetics of TKM, individual herbal material's degree of lipophilicity and metabolic rate, and decoction components according to different kinds of herbal materials were considered. Other factors such as intestinal pH and bacterial activity for metabolism affecting on TKM toxicokinetics, especially in small intestine. It would be a better way for improving the adverse or poor effects caused by TCM if the factors affecting on toxicokinetics of TKM is considered.

Keywords

References

  1. Cheng HM, Li C, Chen CY, Lo HY, Cheng WY, Lee CH, Yang CZ, Wu SL, Hsiang CY, Ho TY. Application of bioactivity database of Chinese herbal medicine on the therapeutic prediction, drug development, and safety evaluation. Journal of Ethnopharmacology. 2010 ; 132 : 429-437. https://doi.org/10.1016/j.jep.2010.08.022
  2. 박영철, 독성학의 분자-생화학적 원리, 한국 학술정보(주), 2010 ; ISBN 9788926812594
  3. Hodgsonm E. "A Textbook of Modern Toxicology". John Wiley and Sons. 2010 ; ISBN 047046206X.
  4. WWW.unmc.edu/physiology, Chapter 1 ; DIFFUSION AND TRANSPORT.
  5. Po HN. Senozan NM. Henderson-Hassel balch Equation : Its History and Limitations. J Chem Educ. 2001 ; 78 : 1499-1503. https://doi.org/10.1021/ed078p1499
  6. de Levie R. The Henderson-Hasselbalch Equation : Its History and Limitations. J Chem Educ. 2003 ; 80 : 146. https://doi.org/10.1021/ed080p146
  7. Colalto C. Review ; Herbal interactions on absorption of drugs : Mechanisms of action and clinical risk assessment. Pharmacological Research. 2010 ; 62 : 207-227. https://doi.org/10.1016/j.phrs.2010.04.001
  8. Butterweck V, Derendorf H. Potential of pharmacokinetic profiling for detecting herbal interactions with drugs. Clin Pharmacokinet. 2008 ; 47(6) : 383-397. https://doi.org/10.2165/00003088-200847060-00003
  9. Zhou W, Di LQ, Shan JJ, Bi XL, Chen LT, Wang LC, Intestinal absorption of forsythoside A in different compositions of Shuang-Huang-Lian Fitoterapia. 2011 ; 82 : 375-382. https://doi.org/10.1016/j.fitote.2010.11.012
  10. Di B, Feng NP, Liu WY. Pharmacokinetic comparisons of Shuang-Huang-Lian with the different combinations of its constitutional herbs. J Ethnopharmacol. 2006 ; 107 : 401-405. https://doi.org/10.1016/j.jep.2006.03.030
  11. Hori Y, Tsuyoshi M, Hirai Y, Fukumura M, Nemoto Y, Toriizuka K, Ida Y. Pharmacognostic studies on ginger and related drugs-part 1 : five sulfonated compounds from Zingiberis rhizome(Shokyo) Phytochemistry. 2003 ; 62 : 613-617. https://doi.org/10.1016/S0031-9422(02)00618-0
  12. Chrubasik S, Pittler MH, Roufogalis BD. Zingiberis rhizoma : A comprehensive review on the ginger effect and efficacy profiles. Phytomedicine. 2005 ; 12 : 684-701. https://doi.org/10.1016/j.phymed.2004.07.009
  13. Dubey AK, Shankar PR, Upadhvava D, Deshpande VY. Ginkgo biloba-an appraisal. Kathmandu Univ Med J. 2004 ; 2(3) : 225- 229.
  14. Hellum BH, Nilsen OG. In vitro inhibition of CYP3A4 metabolism and P-glycoproteinmediated transport by trade herbal products. Basic Clin Pharmacol Toxicol. 2008 ; 102 : 466-475. https://doi.org/10.1111/j.1742-7843.2008.00227.x
  15. Merino G, Molina AJ, Garcia JL, Puldido MM, Prieto JG, Alvarez AI. Ginseng increases intestinal elimination of albendazole sulfoxide in the rat. Comp Biochem Physiol C. 2003 ; 136 : 9-15.
  16. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly : St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging. 2005 ; 22 : 525-529. https://doi.org/10.2165/00002512-200522060-00006
  17. Rajnarayana K, Reddy MS, Vidysagar J, Krishna DR. Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole. Arzneimittelforschung. 2004 ; 54 : 109-113.
  18. Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA. The effect of echinacea(Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther. 2004 ; 75(1) : 89-00. https://doi.org/10.1016/j.clpt.2003.09.013
  19. Lei HP, Wang G, Wang LS, Ou-yang DS, Chen H, Li Q. Lack of effect of Ginkgo biloba on voriconazole pharmacokinetics in chinese volunteers identified as CYP2C19 poor and estensive metabolizers. Ann Pharmacother. 2009 ; 43 : 726-1. https://doi.org/10.1345/aph.1L537
  20. Marzolini C, Paus E, Buclin T, Kim RB. Polymorphisms in human MDR1(Pglycoprotein) : recent advances and clinical relevance. Clin Pharmacol Ther. 2004 ; 75 (1) : 13-23. https://doi.org/10.1016/j.clpt.2003.09.012
  21. Lopez-Rodriguez R, Novalbos J, Gallego- Sandin S, Roman-Martinez M, Torrado J, Gisbert JP. Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers. Pharmacol Res. 2008 ; 58 : 77-4. https://doi.org/10.1016/j.phrs.2008.07.004
  22. 하채림, 장내세균 회복한 후 한약 복용 바 람직－약물과 장내세균의 상호관계를 규명 하기 위한 약물대사기반연구사업단(단장 김 동현)의 연구결과 인용. 연합뉴스. 2010.03.17
  23. 식품의약품안전평가원, 2010-3-17 보도자료
  24. Leung K, Wong A. Pharmacology of ginsenosides : a literature review. Leung and Wong Chinese Medicine. 2010 ; 5 : 20. https://doi.org/10.1186/1749-8546-5-20
  25. Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW. Interactions of Herbs with Cytochrome P450. DRUG METABOLISM REVIEWS. 2003 ; 35(1) : 35-38. https://doi.org/10.1081/DMR-120018248
  26. Chang TK, Chen H, Benetton SA. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1. Drug Metab. Dispos. 2002 ; 30 : 378-384. https://doi.org/10.1124/dmd.30.4.378
  27. Liu Y, Li W, Li P, Deng MC, Yang SL, Yang L. The inhibitory effect of intestinal bacterial metabolite of ginsenosides on CYP3A activity. Biol Pharm Bull. 27(10) : 1555-1560.
  28. Ling Y, Yong L, Chang-Xiao L. Metabolism and pharmacokinetics of ginsenosides. Asian Journal of Pharmacodynamics and Pharmacokinetics. 2006 ; 6(2) : 103-120.
  29. Qiana T, Caia Z, Ricky NS, Wong NKM, Jiang ZH. In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3 Journal of chromatography B. 2005 ; 816 : 223-232. https://doi.org/10.1016/j.jchromb.2004.11.036
  30. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M, Degradation of ginsenosides in humans after oral adninistration. The American Society for Pharmacology and Experimental Therapeutics. 2003 ; 31(8) : 1065-1071.
  31. Heikal OA, Akao T, Takeda S, Hattori M. Pharmacokinetic study of paeonimetabolin I, a major metabolite of paeoniflorin from paeony roots. Biol Pharm Bull. 1997 ; 20 (5) : 517-21. https://doi.org/10.1248/bpb.20.517
  32. Yong L, Ling Y. Early metabolism evaluation making traditional Chinese medicine effective and safe therapeutics. J Zhejiang Univ Science B. 2006 ; 7(2) : 99-106. https://doi.org/10.1631/jzus.2006.B0099
  33. Dietz BM, Liu GK, Hagos P, Yao A, Schinkovitz, SM, Deng PS, Farnsworth GF Pauli RB, vanBreemen JL. Angelica sinensis and its alkylphthalides induce the detoxification enzyme NAD(P)H : quinone oxidoreductase 1 by alkylating Keap1, Chem Res Toxicol. 2008 ; 21(10) : 1939-1948. https://doi.org/10.1021/tx8001274
  34. Yu S, Pang X, Deng Y, Liu L, Liang Y, Liu X, Xie L, Wang G, Wang X. A sensitive and specific liquid chromatography mass spectrometry method for simultaneous determination of berberine, palmatine, coptisine, epiberberine and jatrorrhizine from Coptidis Rhizoma in rat plasma. Phytochemistry. 2003 ; 62 : 613-617. https://doi.org/10.1016/S0031-9422(02)00618-0
  35. Ma BL, Ma YM, Shi R, Wang TM, Zhang N, Wang CH, Yang Y. Identification of the toxic constituents in Rhizoma Coptidis. Journal of Ethnopharmacology. 2010 ; 128 : 357-64. https://doi.org/10.1016/j.jep.2010.01.047